Screener
G&A at other companies
Other financials
Where this comes from
Reported directly by Oscar Health in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Oscar Health’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:24 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001568651-26-000040
| (in thousands, except per share amounts) | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Operating Expenses | ||
| Medical | 3,229,857 | 2,259,651 |
| Selling, general, and administrative | 706,234 | 482,759 |
| Depreciation and amortization | 7,018 | 6,730 |
| Total operating expenses | 3,943,109 | 2,749,140 |
| Earnings from operations | 704,085 | 297,123 |
| Interest expense | 5,383 | 5,994 |
| Other expenses (income) | (71) | 2,918 |
Item 1. Financial Statements
FAQ
- What is Oscar Health's G&A?
- Oscar Health (OSCR) reported G&A of $7.02M in Q1 2026.
- How has Oscar Health's G&A changed year-over-year?
- Oscar Health's G&A increased by 4.3% year-over-year, from $6.73M to $7.02M.
- What is the long-term trend for Oscar Health's G&A?
- Over 3 years (2021 to 2025), Oscar Health's G&A has grown at a -52.2% compound annual growth rate (CAGR), from $265.08M to $28.89M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.
Ask your AI about Oscar Health's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude